
|Articles|November 1, 2003
Iris reconstruction lens benefits aniridic patients
Indianapolis-The Model 311 Iris Reconstruction Lens (Ophtec) appears safe and has significant benefit for reducing visual disturbances in patients with partial or complete aniridia, according to the first reported results from the FDA phase I trial evaluating that implant.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
2
Metformin use associated with reduced incidence of intermediate AMD
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5




























